Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 11, 2021

SELL
$19.71 - $25.23 $45,431 - $58,155
-2,305 Closed
0 $0
Q4 2020

Feb 05, 2021

SELL
$16.44 - $20.2 $120,899 - $148,550
-7,354 Reduced 76.14%
2,305 $45,000
Q3 2020

Oct 30, 2020

BUY
$17.36 - $26.36 $157,403 - $239,006
9,067 Added 1531.59%
9,659 $168,000
Q2 2020

Jul 22, 2020

SELL
$22.31 - $28.29 $22,421 - $28,431
-1,005 Reduced 62.93%
592 $16,000
Q1 2020

May 14, 2020

SELL
$17.75 - $27.72 $24,672 - $38,530
-1,390 Reduced 46.53%
1,597 $39,000
Q4 2019

Feb 10, 2020

BUY
$21.0 - $24.83 $62,727 - $74,167
2,987 New
2,987 $74,000

Others Institutions Holding PAHC

About PHIBRO ANIMAL HEALTH CORP


  • Ticker PAHC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 20,337,600
  • Market Cap $449M
  • Description
  • Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for poultry, swine, beef and dairy c...
More about PAHC
Track This Portfolio

Track Banque Cantonale Vaudoise Portfolio

Follow Banque Cantonale Vaudoise and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

News

Stay updated on Banque Cantonale Vaudoise with notifications on news.